Related Experiment Video
Updated: Feb 6, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Diagnostic value of procalcitonin in ventilator-associated pneumonia
María Florencia Corbacho Re1, Nicolás Sebastián Rocchetti1, Claudio Jesús Settecase1
1Unidad de Cuidados Intensivos, Hospital Eva Perón, Granadero Baigorria, Santa Fe, Argentina.
Insights
Procalcitonin (PCT) did not aid in diagnosing ventilator-associated pneumonia (VAP). This study found no significant differences in PCT levels between patients with and without VAP, suggesting it is not a reliable biomarker for VAP diagnosis.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Procalcitonin (PCT) is a biomarker used for diagnosing bacterial infections and monitoring treatment response.
- Ventilator-associated pneumonia (VAP) is a common hospital-acquired infection in intensive care units (ICUs).
- Early and accurate diagnosis of VAP is crucial for appropriate antibiotic management and patient outcomes.
Purpose of the Study:
- To evaluate the diagnostic value of procalcitonin (PCT) in patients suspected of having ventilator-associated pneumonia (VAP).
- To determine if PCT levels can differentiate between patients with and without VAP.
- To assess the utility of PCT in identifying VAP, particularly in cases with septic shock.
Main Methods:
- A prospective, observational study was conducted over 18 months in a polyvalent Intensive Care Unit (ICU).
- Ninety-one adult patients (over 18 years) with suspected VAP after 48 hours of mechanical ventilation (MV) were included.
- Data collected included demographics, clinical characteristics, severity scores (APACHE II, SAPS II, SOFA), C-reactive protein (CRP), PCT levels, and microbiological results.
Main Results:
- Of 91 patients, VAP was confirmed in 74 (81.3%); 19 (25.7%) presented with septic shock, and overall mortality was 28.4%.
- No statistically significant differences in PCT levels were observed between patients with VAP and those without (P=.449).
- Median PCT levels showed no significant difference across groups: no VAP (0.38), VAP (0.56), and VAP with shock (1.93) (P=.169).
Conclusions:
- Procalcitonin (PCT) did not demonstrate utility as a diagnostic biomarker for ventilator-associated pneumonia (VAP) in this study population.
- The findings suggest that PCT is not a reliable indicator for diagnosing VAP, even in the presence of septic shock.
- Further research may be needed to explore other biomarkers or diagnostic strategies for VAP.
Background And Objective:
Procalcitonin (PCT) can help the early diagnosis of bacterial infections and estimate the response obtained. The objective is to study the value of PCT for the diagnosis of ventilator-associated pneumonia (VAP).
Patients And Method:
Prospective and observational study, carried out for 18 months, in a polyvalent Intensive Care Unit (ICU). Those included were over 18 years of age, with suspected pneumonia after 48h of mechanical ventilation (MV). Collected were demographic characteristics; admission pathology; reason for beginning MV; gravity scores (APACHE II, SAPS II and SOFA); C-reactive protein (CRP) and PCT. At the time of suspicion of VAP: early or late, radiological severity, presence of septic shock, SOFA, CRP, PCT and microbiology.
Results:
Ninety-one patients with suspected VAP were included. The mean age was 42 (17.76) and that of hospitalisation in the ICU was 18.59 (11.69) days. VAP was confirmed in 74 patients, of which 19 (25.7%) presented septic shock. The mortality was 28.4%. There were no significant differences of the PCT in the patients who presented VAP versus those who did not present VAP (P=.449). When patients without VAP, with VAP and VAP with shock, were compared, the PCT median was 0.38 (CI95%: 0.22-1.90), 0.56 (CI95%: 0.19-1.77) and 1.93 (CI95%: 0.38-10.07), respectively (P=.169).
Conclusions:
In our study, PCT did not prove useful for the diagnosis of VAP.
Related Concept Videos
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pulmonary Ventilation: Inhalation
Boyle's law becomes particularly pertinent when examining respiratory...

